Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. - Wikidata - wikimedia - TriplyDB

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

http://www.wikidata.org/entity/Q35127938

about

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes Notes for developing a molecular test for the full characterization of circulating tumor cells Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions Fragment Length of Circulating Tumor DNA Emerging technologies for salivaomics in cancer detection Clinical applications of liquid biopsies in gastrointestinal oncology Origins, structures, and functions of circulating DNA in oncology Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping.Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancer Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.Cancer biomarker discovery and validation.Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD.A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.Development and validation of an ultra-deep next-generation sequencing assay for testing of plasma cell-free DNA from patients with advanced cancer.Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.Liquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB)PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients Changing paradigm of cancer therapy: precision medicine by next-generation sequencing.Establishment and application of a real-time loop-mediated isothermal amplification system for the detection of CYP2C19 polymorphisms.

P2860

Q26765922-84DF1C8E-6ECA-4760-ADC9-A7345D3FF273 Q26778913-60701545-3F6E-4CE0-BBCA-ED547EF00AE0 Q26781333-359C2606-25C5-43B6-ACB8-B7C811823125 Q27308628-803EC2EB-E702-43F2-847A-F7858228F83A Q28069566-5FC84A86-6B99-4562-9EC1-45C1AF68DCC3 Q28073730-362CDD83-87E3-408D-B54E-6F14511948AD Q30249103-E37CF8EC-3882-425F-9F4D-C711444370F0 Q33620743-77488FFE-57A7-4718-99B9-B5D46892665A Q33673752-4B12EC4E-F847-445F-ADC9-5B6B37949698 Q33679694-D9A2AB12-27E3-47D4-9171-0349BDBF6783 Q34457501-6F26C68A-1ECE-4F8C-85C2-78543EBBF987 Q34457638-4B26F8CD-A103-417C-8E0D-10E3C52B006A Q34662946-7BB27837-E310-4194-A96A-8B0DDB36CB01 Q34748747-A3172C14-BA30-42DC-852D-C0E425A79EDE Q35068013-D7C7FAB1-6AD3-4357-BE43-49B66EBF8B24 Q35576801-208CE9B5-168E-439B-96FC-AE7D9635CD91 Q35709696-7A4811D3-52D4-4E10-A022-6B9D24989BDC Q35828697-A62B06A2-DB29-460C-8FB5-7F7D33F55327 Q35839745-664EDC50-A75B-4AA7-ADB7-12124E6E6EFC Q35877954-2A1D483E-62EE-424F-9FA9-4B536BF1E3B2 Q35879887-71866EF6-F2FB-4932-961D-C69416C64EA5 Q36038684-AF475617-4860-40C0-AE04-227F5CBE8E10 Q36091092-6A97257C-BE01-47BF-A472-117DAC91D40F Q36103228-E2F6E22B-BB05-4276-BC25-CBE80A1056AF Q36104839-308C31AA-B36B-4F7D-802E-362BE9DC446D Q36188885-C4AE6827-0F66-428C-B4A3-5387AB301C5C Q36233903-E6C3360B-6F46-40D5-A8A0-B6B494DEDA45 Q36243135-62F794A9-3F94-464B-8B07-109FBC0F98B9 Q36277022-B8C5B381-533D-4FAD-B576-D6B13257B86E Q36278318-BE3043EC-748F-4977-A219-8E6A61BF256A Q36292534-0B46FB67-275C-4FFC-B200-73114D8A7D49 Q36318273-22D3F67F-E692-4439-A019-A4B86415C0F4 Q36378903-516C4BCD-7623-410B-AA9E-C87B5D314390 Q36416491-C1D6FE77-00E1-43D9-BFB0-AD9C85AE6F37 Q36430821-5AD3E444-F280-467F-8C89-3CE183A974B7 Q36545534-6949DF7A-DF64-4EEA-8E3A-2D7B6B04F682 Q36645051-EAB258EB-5D63-47B4-8D26-CBC2AE09B0CB Q36846985-0CF1AA38-A3C6-4F21-AF6B-EA7714E45F9D Q36849642-6F718169-4324-44B1-A621-19C3300E6ED2 Q36953706-6CA6FF20-07D0-4D54-842B-2F359A139195

P2860

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

http://www.wikidata.org/entity/Q35127938

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical validation of the det ...... ns from circulating tumor DNA.

@ast

Clinical validation of the det ...... ns from circulating tumor DNA.

@en

type

label

Clinical validation of the det ...... ns from circulating tumor DNA.

@ast

Clinical validation of the det ...... ns from circulating tumor DNA.

@en

prefLabel

Clinical validation of the det ...... ns from circulating tumor DNA.

@ast

Clinical validation of the det ...... ns from circulating tumor DNA.

@en

P1433

Q35127938-8C2ACBAF-8BB0-4BDD-A765-D52B6DFEF0AC

P1476

Q35127938-55CF6109-F4AE-4781-B80D-5CAB4EEDB0B7

P2093

Q35127938-0E583D37-3AA4-4BBA-8AC3-919C5EF19C3F

Q35127938-1B8E5122-DF36-4662-A0EB-CB9E90356454

Q35127938-30B0E989-8AA0-42AF-B6F0-2932D2BBA723

Q35127938-379B0D0A-7179-4732-9033-B267DC535DC7

Q35127938-3C14BF68-01A3-4719-B928-4511FA6EB52D

Q35127938-45E131A5-1701-443A-860F-3768146D8F7E

Q35127938-532BF021-E784-4407-BD17-2FAE8C73EB63

Q35127938-611A25CD-FC53-4861-BE6B-E8685146809B

Q35127938-75B98A4E-76E4-471A-8030-B4DEAC3DAF4B

Q35127938-77FB260A-5DE7-4F3B-9EE8-3BD20E895C40

P2888

Q35127938-6FE2C2AF-B80E-4A04-A730-425E500D79F9

P304

Q35127938-A271A527-93ED-4C59-A2E8-6C79B1E335CE

P31

Q35127938-8FC9D27D-5161-4939-857E-1084F6B8018B

P356

Q35127938-BB02DD49-FE3D-4C51-AE5B-3678F5005BD5

P407

Q35127938-A989E785-DA04-4A68-BF14-B6E523B58723

P433

Q35127938-911F6977-73C3-42F6-83AC-5F64BA1AA85A

P478

Q35127938-20CDF0D8-5698-412F-B0FE-7029DDE91E76

P50

Q35127938-0A746B23-13E3-43E1-BDA3-01AD4A18018B

Q35127938-182449DD-AC6C-4F89-88DD-BF67C0B73757

Q35127938-62B35ABD-E4B1-4BB6-B8A3-5085285A7470

Q35127938-888CF0F4-049C-44E7-8054-3306ECCB962E

P577

Q35127938-A34E4F62-43C7-4451-AB89-7365525C19FF

P5875

Q35127938-40596702-D0B3-4DF0-A177-B9C21CD87475

P698

Q35127938-8A2E16DA-73AC-410D-A51C-661DB56C6BCE

P356

P1433

Nature Medicine

P1476

Clinical validation of the det ...... ons from circulating tumor DNA

@en

P2093

Alain R Thierry

http://www.w3.org/2001/XMLSchema#string

Anne-Sophie Jarrousse

http://www.w3.org/2001/XMLSchema#string

Brigitte Gillet

http://www.w3.org/2001/XMLSchema#string

Bruno Robert

http://www.w3.org/2001/XMLSchema#string

Caroline Mollevi

http://www.w3.org/2001/XMLSchema#string

Celine Gongora

http://www.w3.org/2001/XMLSchema#string

Denis Pezet

http://www.w3.org/2001/XMLSchema#string

Evelyne Lopez-Crapez

http://www.w3.org/2001/XMLSchema#string

Fanny Rolet

http://www.w3.org/2001/XMLSchema#string

Franck Molina

http://www.w3.org/2001/XMLSchema#string

P2888

P304

430-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.3511

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Pierre-Jean Lamy

Florent Mouliere

Muriel Mathonnet

P577

2014-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261033556

http://www.w3.org/2001/XMLSchema#string

P698

24658074

http://www.w3.org/2001/XMLSchema#string